Search Results - "Heider, Robin M."

An Assay that Predicts In Vivo Efficacy for DNA Aptamers that Stimulate Remyelination in a Mouse Model of Multiple Sclerosis by Heider, Robin M, Smestad, John A, Lemus, Hernan Nicolas, Wilbanks, Brandon, Warrington, Arthur E, Peters, Justin P, Rodriguez, Moses, Maher, 3rd, L James

“…Multiple sclerosis (MS) is a debilitating disease for which regenerative therapies are sought. We have previously described human antibodies and DNA…”
Get full text

IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study by Ho, Ming-Fen, Zhang, Cheng, Cohan, James S., Tuncturk, Mustafa, Heider, Robin M., Coombes, Brandon J., Biernacka, Joanna, Moon, Irene, Skime, Michelle, Ho, Ada M, Ngo, Quyen, Skillon, Cedric, Croarkin, Paul E., Oesterle, Tyler S., Karpyak, Victor M., Li, Hu, Weinshilboum, Richard M.

“…•Baseline plasma inflammatory markers were associated with acamprosate treatment outcomes.•Lower baseline IL17RB expression was associated with alcohol…”
Get full text

Optimization of a 40-mer Antimyelin DNA Aptamer Identifies a 20-mer with Enhanced Properties for Potential Multiple Sclerosis Therapy by Wilbanks, Brandon, Smestad, John, Heider, Robin M, Warrington, Arthur E, Rodriguez, Moses, Maher, 3rd, L James

“…We previously reported the selection and characterization of a DNA aptamer capable of stimulating remyelination in a mouse model of multiple sclerosis. This…”
Get more information

A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next? by Perwein, Maria K, Smestad, John A, Warrington, Arthur E, Heider, Robin M, Kaczor, Mark W, Maher, 3rd, Louis J, Wootla, Bharath, Kunbaz, Ahmad, Rodriguez, Moses

“…Multiple sclerosis (MS) is a chronic and progressive inflammatory demyelinating disease of the human central nervous system (CNS) and is the most common…”
Get more information